The bare skin and the nose as non-invasive routes for administering peptide vaccines
- 14 March 2001
- Vol. 19 (17-19) , 2708-2715
- https://doi.org/10.1016/s0264-410x(00)00507-7
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Melanoma Peptide MART-1(27−35) Analogues with Enhanced Binding Capacity to the Human Class I Histocompatibility Molecule HLA-A2 by Introduction of a β-Amino Acid Residue: Implications for Recognition by Tumor-Infiltrating LymphocytesJournal of Medicinal Chemistry, 2000
- Antipeptide Antibody Responses following Intranasal Immunization: Effectiveness of Mucosal AdjuvantsInfection and Immunity, 2000
- Exploration of Requirements for Peptidomimetic Immune RecognitionJournal of Biological Chemistry, 1996
- The adjuvant effect of a non‐toxic mutant of heat‐labile enterotoxin of Escherichia coli for the induction of measles virus‐specific CTL responses after intranasal co‐immunization with a synthetic peptideImmunology, 1996
- Structural limitations to antigenic mimicry achievable with retroinverso (all-D-retro) peptidesTrends in Biotechnology, 1996
- Recent developments in retro peptides and proteins — an ongoing topochemical explorationTrends in Biotechnology, 1995
- Liposomes as Carriers of Peptide Antigens: Induction of Antibodies and Cytotoxic T Lymphocytes to Conjugated and Unconjugated PeptidesImmunological Reviews, 1995
- CpG motifs in bacterial DNA trigger direct B-cell activationNature, 1995
- The skin immune system: progress in cutaneous biologyImmunology Today, 1993
- The role of nasopharyngeal lymphoid tissueImmunology Today, 1992